Literature DB >> 7914662

Measurement of GABA following GABA-transaminase inhibition by gabaculine: a 1H and 31P NMR spectroscopic study of rat brain in vivo.

K L Behar1, D Boehm.   

Abstract

A selective 1H NMR spin-echo editing method was used to detect the 4-CH2 of GABA in rat brain in vivo before and after intravenous administration of the highly selective GABA transaminase inhibitor, gabaculine (3-amino-2,3-dihydrobenzoic acid-HCl; 100 mg/kg, intravenously). The effects of the inhibitor on high energy phosphates and pHi were determined by 31P NMR. GABA levels increased approximately linearly (r = 0.81 to 0.94; P < 0.0005) from 1.9 +/- 0.4 mumol/g (pre-gabaculine; mean +/- SD) to between 6 and 8 mumol/g after 4 hr at rates of accumulation of 1.1 to 2.9 mumol/hr/g. 1H NMR spectroscopic measurements of cerebral GABA and its rate of turnover offers a new approach in the study of GABA-mediated processes in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7914662     DOI: 10.1002/mrm.1910310612

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  8 in total

1.  Vigabatrin, a GABA transaminase inhibitor, reversibly eliminates tinnitus in an animal model.

Authors:  Thomas J Brozoski; T Joseph D Spires; Carol A Bauer
Journal:  J Assoc Res Otolaryngol       Date:  2007-01-13

2.  Preliminary evidence of reduced occipital GABA concentrations in puerperal women: a 1H-MRS study.

Authors:  C Neill Epperson; Ralitza Gueorguieva; Kathryn A Czarkowski; Stephanie Stiklus; Edward Sellers; John H Krystal; Douglas L Rothman; Graeme F Mason
Journal:  Psychopharmacology (Berl)       Date:  2006-05-03       Impact factor: 4.530

Review 3.  Measuring human brain GABA in vivo: effects of GABA-transaminase inhibition with vigabatrin.

Authors:  O A Petroff; D L Rothman
Journal:  Mol Neurobiol       Date:  1998-02       Impact factor: 5.590

4.  The rate of turnover of cortical GABA from [1-13C]glucose is reduced in rats treated with the GABA-transaminase inhibitor vigabatrin (gamma-vinyl GABA).

Authors:  D Manor; D L Rothman; G F Mason; F Hyder; O A Petroff; K L Behar
Journal:  Neurochem Res       Date:  1996-09       Impact factor: 3.996

5.  Detection of reduced GABA synthesis following inhibition of GABA transaminase using in vivo magnetic resonance signal of [13C]GABA C1.

Authors:  Jehoon Yang; Christopher Johnson; Jun Shen
Journal:  J Neurosci Methods       Date:  2009-06-21       Impact factor: 2.390

6.  A neuronal glutamate transporter contributes to neurotransmitter GABA synthesis and epilepsy.

Authors:  Jehuda P Sepkuty; Akiva S Cohen; Christine Eccles; Azhar Rafiq; Kevin Behar; Raquelli Ganel; Douglas A Coulter; Jeffrey D Rothstein
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

7.  In vivo γ-aminobutyric acid measurement in rats with spectral editing at 4.7T.

Authors:  Stephen J Sawiak; Bianca Jupp; Tom Taylor; Daniele Caprioli; T Adrian Carpenter; Jeffrey W Dalley
Journal:  J Magn Reson Imaging       Date:  2015-12-03       Impact factor: 4.813

8.  Pain Perception, Brain Connectivity, and Neurochemistry in Healthy, Capsaicin-Sensitive Subjects.

Authors:  Stefanie Heba; Matthias Sczesny-Kaiser; Kirsten Sucker; Jürgen Bünger; Thomas Brüning; Martin Tegenthoff; Tobias Schmidt-Wilcke
Journal:  Neural Plast       Date:  2020-10-28       Impact factor: 3.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.